Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Yervoy
Yervoy
Opdivo combo shows early survival benefit in kidney cancer
BioPharma Dive
Fri, 09/8/17 - 09:34 am
Opdivo
Yervoy
Bristol-Myers Squibb
kidney cancer
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer
Xconomy
Wed, 08/16/17 - 10:13 am
Bristol-Myers Squibb
kidney cancer
Opdivo
Yervoy
FDA Considers Label Changes for Keytruda, Opdivo and Yervoy
RAPS.org
Wed, 07/12/17 - 02:41 pm
FDA
labeling
Keytruda
Opdivo
Yervoy
immuno-oncology
Merck
Bristol-Myers Squibb
Bristol-Myers’ tarnished checkpoint star Opdivo beats out Yervoy in surprise PhIII
Endpoints
Wed, 07/5/17 - 10:00 am
Bristol-Myers Squibb
Opdivo
Yervoy
melanoma
Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact
Endpoints
Wed, 04/19/17 - 04:17 pm
Bristol-Myers Squibb
cancer
vaccines
Bavarian Nordic
Prostvac
Opdivo
Yervoy
Bristol-Myers Squibb says cancer drug combination 'significantly' improved survival in late-stage melanoma trial
Marketwatch
Tue, 04/4/17 - 11:01 pm
Bristol-Myers Squibb
Opdivo
Yervoy
melanoma
Bristol-Myers shares drop after company says it will not seek fast-track drug approval
CNBC
Sat, 01/21/17 - 11:52 am
Bristol-Myers Squibb
fast track
lung cancer
Opdivo
Yervoy
Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Xtalks
Mon, 11/7/16 - 09:17 pm
immuno-oncology
heart damage
Opdivo
Yervoy
Bristol-Myers Squibb
anti-PD-1 immunotherapy
New Bristol-Myers Squibb Research on Opdivo (nivolumab) Monotherapy and in Combination With Yervoy (ipilimumab) at SMR 2016 Congress Reinforces Immuno-Oncology Leadership and Scientific Expertise in Melanoma
Yahoo
Mon, 10/31/16 - 09:08 am
Bristol-Myers Squibb
Opdivo
Yervoy
melanoma
Will Bristol-Myers Squibb Co (BMY) Recover From Its Recent Slump?
Bidness, ETC
Mon, 08/15/16 - 09:46 pm
Bristol-Myers Squibb
Opdivo
Yervoy
non-small cell lung cancer
Bristol-Myers Squibb Promises To Publish Failed Study After Long Delay
Forbes
Mon, 06/6/16 - 11:04 pm
Bristol-Myers Squibb
Yervoy
clinical trials
prostate cancer
Bristol-Myers’s Drug Combination Boosts Lung Cancer Benefit
Bloomberg
Sat, 06/4/16 - 06:23 pm
Bristol-Myers Squibb
Yervoy
Opdivo
metastatic non-small cell lung cancer
9 Drugs That Cost Medicare a Fortune
Motley Fool
Sun, 04/10/16 - 01:29 pm
Medicare
Lucentis
Eylea
Prolia
Treanda
Lexiscan
Yervoy
Privigen
Provenge
Soliris
Bristol-Myers Cancer Drug Combination to Cost $256,000 a Year
Bloomberg
Thu, 10/1/15 - 02:16 pm
Bristol-Myers Squibb
Opdivo
Yervoy
drug pricing
melanoma
skin cancer
FDA approves Bristol-Myers drug combination for skin cancer
Yahoo/Reuters
Thu, 10/1/15 - 09:22 am
FDA
Bristol-Myers Squibb
skin cancer
Opdivo
Yervoy
Incyte Hits High On Cancer Drug Data, Buyout Talk
Investors.com
Fri, 09/11/15 - 05:56 pm
Incyte
M&A
epacadostat
Yervoy
melanoma
Bristol-Myers Squibb
New data expected at lung-cancer conference on experimental drug combos
Medical Marketing and Media
Fri, 09/4/15 - 09:01 am
lung cancer
Opdivo
Yervoy
Bristol-Myers Squibb
tremelimumab
MEDI4736
AstraZeneca
Roche
atezolizumab
Should Bristol-Myers cut payer deals to boost melanoma combo over one-drug treatments?
Fierce Pharma Marketing
Mon, 06/29/15 - 11:32 am
melanoma
Bristol-Myers Squibb
payer negotiation
Yervoy
Opdivo
Pairing of Two Bristol-Myers Drugs Sees Success in Battling Skin Cancer, Study Says
WSJ Online
Sun, 05/31/15 - 11:23 am
Bristol-Myers Squibb
Opdivo
Yervoy
Bristol-Myers Squibb's Next 8 Months: What To Expect
Yahoo/Benzinga
Wed, 04/29/15 - 10:12 am
Bristol-Myers Squibb
Opdivo
Yervoy
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »